Listen Live
Donate
 on air
Schedule

KCRW

Read & Explore

  • News
  • Entertainment
  • Food
  • Culture
  • Events

Listen

  • Live Radio
  • Music
  • Podcasts
  • Full Schedule

Information

  • About
  • Careers
  • Help / FAQ
  • Newsletters
  • Contact

Support

  • Become a Member
  • Become a VIP
  • Ways to Give
  • Shop
  • Member Perks

Become a Member

Donate to KCRW to support this cultural hub for music discovery, in-depth journalism, community storytelling, and free events. You'll become a KCRW Member and get a year of exclusive benefits.

DonateGive Monthly

Copyright 2025 KCRW. All rights reserved.

Report a Bug|Privacy Policy|Terms of Service|
Cookie Policy
|FCC Public Files

Back to To the Point

To the Point

How Safe Are Our Prescription Drugs?

With 80 people dead after using a contaminated blood thinner imported from China, the head of the Food and Drug Administration faced withering cross examination from a Congressional subcommittee this week. If a drug is tested by scientists, does that mean it's safe? What if the scientists took money from the company that made the drug?

  • rss
  • Share
KCRW placeholderBy Lawrence O'Donnell • May 12, 2014 • 1 min read

With 80 people dead after using a contaminated blood thinner imported from China, the head of the Food and Drug Administration faced withering cross examination from a Congressional subcommittee this week. If a drug is tested by scientists, does that mean it's safe? What if the scientists took money from the company that made the drug? Would more oversight slow down the process too much? Shouldn't the FDA be able to guarantee the safety of our prescriptions?

  • KCRW placeholder

    Lawrence O'Donnell

    MSNBC

  • Sonya Geis with wavy brown hair wearing a black dress with red accents and decorative earrings against a white background.

    Sonya Geis

    Senior Managing Editor

  • KCRW placeholder

    Katie Cooper

    Producer, 'One year Later'

  • KCRW placeholder

    Peter Pitts

    former Associate Commissioner, Food and Drug Administration

  • KCRW placeholder

    Eric Meslin

    Director of the Center for Bioethics, Indiana University

  • KCRW placeholder

    Phil Fontanarosa

    Executive Deputy Director, Journal of the American Medical Association

    NewsNationalPolitics
Back to To the Point